Skip to main content

Month: February 2021

Bonduelle – Statement of availability of Half-Year Financial report on December 31, 2020

BONDUELLEA French SCA (Partnership Limited by Shares) with a capital of 56 942 095 EurosHead Office: La Woestyne 59173 Renescure, FranceRegistered under number: 447 250 044 (Dunkerque Commercial and Companies Register)Villeneuve d’Ascq, on February 26, 2021Statement of availabilityof the Half-Year Financial Report on December 31, 2020The company today announces that it released its Half Year Report on December 31, 2020 and filed the report at the AMF.The Half Year Report is available on the website of the company at the following address: www.bonduelle.com under the topic “Investors / Regulated information” (http://www.bonduelle.com/en/investors/regulated-information.html).AttachmentStatement of availability of HY 20-21 Financial report

Continue reading

Bonduelle – Mise à disposition du rapport financier semestriel au 31 décembre 2020

BONDUELLESociété en commandite par actions au capital de 56 942 095 eurosSiège social : “La Woestyne” 59173 – RenescureRCS Dunkerque 447 250 044Villeneuve d’Ascq, le 26 février 2021Communiqué de mise à dispositiondu rapport financier semestriel au 31 décembre 2020La société annonce ce jour avoir mis à la disposition du public et déposé auprès de l’Autorité des marchés financiers son rapport financier semestriel au 31 décembre 2020.Le rapport financier semestriel peut être consulté sur le site internet de la société à l’adresse www.bonduelle.com, dans la rubrique « Finance / Informations réglementées » (http://www.bonduelle.com/fr/finance/informations-reglementees.html).Pièce jointeCommunique_RFS_311220

Continue reading

Municipality Finance Plc amends the terms and conditions of medium term notes

Municipality Finance PlcStock exchange release26 February 2021 at 10:30 am (EET)Municipality Finance Plc amends the terms and conditions of medium term notesMunicipality Finance Plc amends the terms and conditions pertaining to interest payments of USD 10 million medium term notes issued on 18 July 2019 (ISIN: XS2027954127). With the amendments, the notes bear interest at fixed rate of 2.27 per cent. per annum for all interest periods from the interest period beginning in July 2021. Prior to the amendments, the interest for these interest periods was determined with reference to USD Constant Maturity Swap (CMS) rates. The amendment is intended to remove dependence to LIBOR rates which are expected to be discontinued in the coming years. USD CMS rates are determined with reference to LIBOR rates. In other respects, the terms and conditions...

Continue reading

Kuntarahoitus Oyj muuttaa joukkovelkakirjalainan ehtoja

Kuntarahoitus OyjPörssitiedote26.2.2021 klo 10.30Kuntarahoitus Oyj muuttaa joukkovelkakirjalainan ehtojaKuntarahoitus Oyj muuttaa 18.7.2019 liikkeeseen laskemansa 10 miljoonan Yhdysvaltain dollarin joukkovelkakirjalainan (ISIN: XS2027954127) koronmaksua koskevia ehtoja. Muutoksen jälkeen kaikille korkokausille heinäkuussa 2021 alkavalta korkokaudelta alkaen maksetaan 2,27 prosentin vuosittaista kiinteää korkoa aiemman USD Constant Maturity Swap (CMS) -korkojen perusteella määräytyvän koron sijaan. Muutoksen tarkoituksena on poistaa joukkovelkakirjalainan koron sidonnaisuus LIBOR-korkoihin, joiden noteerauksen odotetaan päättyvän lähivuosina. USD CMS -korot määräytyvät LIBOR-korkojen perusteella. Muilta osin joukkovelkakirjalainan ehdot pysyvät ennallaan. Joukkovelkakirjan haltijat ovat hyväksyneet muutokset ja ne astuvat voimaan 26.2.2021.Joukkovelkakirjalaina...

Continue reading

Abonnementer løfter cBrains omsætningsvækst til 25%

Fondsbørsmeddelelse nr. 06/2021Abonnementer løfter cBrains omsætningsvækst til 25%København, 26. februar 2021Regnskabet viser en markant udvikling. Det gælder omsætning, indtjening og ikke mindst nøgletallene for abonnementssalg og eksport, som er centrale i forhold til vækstplanen.Omsætningen er vokset fra 96,4 mio. kroner i 2019 til 120,1 mio. kroner i 2020, svarende til en omsætningsvækst på 25%.Indtjening før skat (EBT) er vokset fra 10,8 mio. kroner i 2019 til 20,1 mio. kroner i 2020, svarende til en indtjening på 17% og vækst i indtjening på 86%.Salget af softwareabonnementer er vokset fra 45,7 mio. kroner i 2019 til 63,8 mio. kroner i 2020, svarende til en vækst i salg af softwareabonnementer på 40%.Det betyder, at softwareabonnementer udgør 53% af den samlede omsætning. Den øvrige del af omsætningen vedrører salg af timer i forbindelse...

Continue reading

Pinduoduo recognized for work on alleviating poverty in China

SHANGAHI, China, Feb. 26, 2021 (GLOBE NEWSWIRE) — Pinduoduo Inc. (“Pinduoduo”, or the “Company”) (NASDAQ: PDD), China’s largest agricultural platform, was recognized for its efforts in alleviating rural poverty.Pinduoduo was one of three technology companies commended for their contributions to China’s poverty alleviation efforts, according to a central government release. A total of 1,981 individuals and 1,501 organizations, institutions and companies were honored.“The commendation is both an affirmation and timely reminder of Pinduoduo’s social responsibility to help better the lives of the communities in which we operate in,” said Chen Lei, Chief Executive Officer of Pinduoduo. “We will always dedicate ourselves to do the right things, to create value for society, and to make this world a better and happier place.”Pinduoduo has...

Continue reading

Corline Biomedical AB publicerar bokslutskommuniké för 2020

Corline Biomedical AB (”Corline”) publicerar härmed bokslutskommuniké för det fjärde kvartalet och räkenskapsåret 2020. Nedan följer en kort sammanfattning av bokslutskommunikén. Fullständig bokslutskommuniké finns tillgänglig på Corlines hemsida (www.corline.se) samt som bifogad fil.VD Henrik Nittmar kommenterar”När nuvarande kunders produkter med CHS-yta erhåller kommersiellt godkännande uppskattar Corline den årliga potentialen till 85 MSEK på några års sikt. Med årets framgångar i ryggen inom medicinteknik är målet utstakat att ytterligare öka affärspotentialen genom fler kundprojekt och avtal.”Väsentliga händelser under det fjärde kvartaletLeverans- och supportavtal tecknas i oktober med det amerikanska bolaget Imperative Care för användning av Corlines antitrombotiska ytbehandling CHS™ för produkter inom strokevård. Totalt försäljningsvärde...

Continue reading

Fluidra closes an excellent 2020 with record sales and profit

Sales stood at 1,488 million euros, up 8.8%, and EBITDA increased by 19.3% to 321 million euros, with a 21.6% margin.Excellent cash generation has reduced Net Debt/EBITDA leverage to 1.8x.The company is confident that 2021 will be very positive and expects to increase sales by 6% to 9%.26 February 2021 – Fluidra, a global leader in pool and wellness equipment, closed 2020 with its best results ever. The company ended the year with sales of 1,488 million euros, up 8.8% and 11.0% on constant FX and perimeter compared to 2019, driven by the high demand in Residential Pool. Net profits stood at 96 million euros, more than 11 times higher than in 2019, when they were affected by merger related non-recurring expenses.EBITDA was up 19.3% to 321 million euros, well ahead of the 12% annualized guidance of our Strategic Plan. This positive operational...

Continue reading

Biophytis Reports 2020 Full Year Results

PARIS and CAMBRIDGE, Mass., Feb. 26, 2021 (GLOBE NEWSWIRE) — Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “Company”), a clinical-stage biotechnology company focused on the development of therapeutics that are aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, today announces its non-audited financial results for the year ended December 31, 2020, and provides updates on key operational developments and financing transactions.• Major milestones achieved during 2020Launch of the phase 2-3 COVA trial assessing Sarconeos (BIO101) as a potential treatment for acute respiratory failure linked to COVID-19global, multicenter, double-blind,...

Continue reading

DIGITALIST GROUP’S FINANCIAL STATEMENT RELEASE, 1 JANUARY–31 DECEMBER 2020

DIGITALIST GROUP PLC      STOCK EXHANGE RELEASE    26 February 2021 9:00 AMDIGITALIST 2020SUMMARYOctober–December 2020 (comparable figures for 2019 in parentheses):●        Turnover: EUR 5.0 million (EUR 6.7 million), decrease: -25.0%.●        EBITDA: EUR 0.3 million (EUR -1.7 million), 5.6% of turnover (-24.9%).●        EBIT*: EUR -0.9 million (EUR -9.5 million), -17.5% of turnover (-140.9%).●        Net income*: EUR -1.6 million (EUR -9.5 million), -32,0% of turnover (-140.4 %).●         Earnings per share (diluted and undiluted) EUR -0.00 (EUR -0.02).    *Comparison year EBIT and net income include a goodwill impairment charge of EUR -7.0 million.    January–December 2020 (comparable figures for 2019 in parentheses):●        Turnover: EUR 20.5 million (EUR 27.4 million), decrease: -25.2%.●        EBITDA: EUR -2.0 million (EUR -3.7 million),...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.